The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Apologies Regulator you are correct and I meant no disrespect for the NHS. Those posting on this board are very aware of the MHRA and the DHSC and the different parts they pay. I was perhaps lazy with my wording but you will agree the the packaging is NHS, the user guide is presented by the NHS and it is commonly known as NHS Test and Trace.
" The NHS decided to give it EUA when they felt the demand was greater than what could be UK supplied - they will answer for that decision in time. "
The NHS didn't make any decision in relation to the Innova test.
The MHRA gave it EUA at the request of the DHSC. The MHRA is an executive agency sponsored by the DHSC.
Test & Trace are using the test at the behest of DHSC. Test & Trace is not the NHS.
Let’s just stop and think - Innova test has largely been discredited by FDA action but whatever it’s actual effectiveness it certainly appears to have helped us reduce the transmission of COVID. The NHS decided to give it EUA when they felt the demand was greater than what could be UK supplied - they will answer for that decision in time. Since then they have supported UK manufacturing including ODX to prepare for a time when a better sovereign test could be produced at scale. The FDA have certainly called out Innova for supplying to the US without authorisation but LFT remain a cornerstone of Joe Biden policy to defeat COVID it will also remain as a cornerstone of UK policy. HMG will have been alerted FDA findings and we already new that the EUA for Innova was due to be reviewed on 21st June, that is I week away. Even before the report many of us had anticipated it would not be renewed. The UK is ready, the haters will use this time to try and create a wobble and interested parties will take as much political advantage as they can but a proper gold standard sovereign test, supplied by ODX and two other UK companies will mean that we can expect LFT, as the only viable option for mass testing to be around for years to come. The bottom line for me is that with the potential demise of Innova test kits HMG are if anything likely to want to increase their anticipated order from 50 million per annum to our current maximum 100m production. Do well fear not.